enow.com Web Search

  1. Ads

    related to: b cell lymphoma treatment

Search results

  1. Results from the WOW.Com Content Network
  2. B-cell lymphoma - Wikipedia

    en.wikipedia.org/wiki/B-cell_lymphoma

    The B-cell lymphomas are types of lymphoma affecting B cells. Lymphomas are "blood cancers" in the lymph nodes . They develop more frequently in older adults and in immunocompromised individuals.

  3. Germinal center B-cell like diffuse large B-cell lymphoma

    en.wikipedia.org/wiki/Germinal_center_B-cell...

    CD20. Approximately 95% of B-cell lymphomas express CD20, but CD20 is not critical for B-cell survival. Clonal B-cells spontaneously mutate the idiotypic region of their immunoglobulin. This high mutation rate makes them prone to the selection of B-cells lacking the CD20 antigen following treatment with CD20-targeting monoclonal antibodies.

  4. Diffuse large B-cell lymphoma - Wikipedia

    en.wikipedia.org/wiki/Diffuse_large_B-cell_lymphoma

    Diffuse large B-cell lymphoma (DLBCL) is a cancer of B cells, a type of lymphocyte that is responsible for producing antibodies.It is the most common form of non-Hodgkin lymphoma among adults, [1] with an annual incidence of 7–8 cases per 100,000 people per year in the US and UK.

  5. Non-Hodgkin lymphoma - Wikipedia

    en.wikipedia.org/wiki/Non-Hodgkin_lymphoma

    The most common chemotherapy used for B-cell non-Hodgkin lymphoma is R-CHOP, which is a regimen of four drugs (cyclophosphamide, doxorubicin, vincristine, and prednisone) plus rituximab. [ 33 ] R-CHP with polatuzumab vedotin , an antibody-drug conjugate, was included as a category 1 preferred regimen for first-line DLBCL by the National ...

  6. Loncastuximab tesirine - Wikipedia

    en.wikipedia.org/wiki/Loncastuximab_tesirine

    Loncastuximab tesirine, sold under the brand name Zynlonta, is a monoclonal antibody conjugate medication used to treat large B-cell lymphoma and high-grade B-cell lymphoma. [1] [2] It is an antibody-drug conjugate (ADC) composed of a humanized antibody targeting the protein CD19. [1]

  7. The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies, including follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). [7] In addition to cure-directed treatment, people can benefit from self-care to manage symptoms.

  1. Ads

    related to: b cell lymphoma treatment